| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Intangible assets, net | 7,622,041 | |||
| Prepaid expenses and other current assets | 873,789 | |||
| Cash | 2,218,331 | |||
| Total current assets | 3,092,120 | |||
| Total assets | 10,714,161 | |||
| Accrued expenses | 623,661 | |||
| Loans payable related parties - current portion-Related Party | 650,000 | |||
| Loans payable - current portion | 762,445 | |||
| Accounts payable related parties-Related Party | 1,093,432 | |||
| Accounts payable | 2,204,060 | |||
| Total current liabilities | 5,333,598 | |||
| Loans payable - noncurrent portion | 0 | |||
| Total liabilities | 5,333,598 | |||
| Treasury stock | 1,000,000 | |||
| Accumulated deficit | -145,619,180 | |||
| Preferred stock, value-Class KPreferred Stock | 0 | |||
| Preferred stock, value-Class CPreferred Stock | 0 | |||
| Preferred stock, value-Class BConvertible Preferred Stock | 0 | |||
| Preferred stock, value | 0 | |||
| Common stock, 0.0001 par value 100,000,000 shares authorized 6,039,208 and 3,176,999 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively | 604 | |||
| Additional paid-in capital | 155,124,183 | |||
| Accumulated other comprehensive income | -3,125,044 | |||
| Total stockholders equity | 5,380,563 | |||
| Total liabilities and stockholders equity | 10,714,161 | |||
180 Life Sciences Corp. (ATNF)
180 Life Sciences Corp. (ATNF)